Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma
NCT00044863
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Neoplasms
Metastases, Neoplasm
Interventions
BIOLOGICAL:
Erbitux (Cetuximab)
Sponsor
Eli Lilly and Company